Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease

Tissue Antigens

Volumn 67, Issue 3, 2006, Pages 183-197

  Krawczyk, M ^a   Reith, W ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Bare lymphocyte syndrome; CIITA; Gene regulation; MHC class II; NOD LRR; RFX; Transcription

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIGEN EXPRESSION; BARE LYMPHOCYTE SYNDROME; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RFX5 GENE; RFXANK GENE; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MODELS, IMMUNOLOGICAL; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 33644932200     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00557.x     Document Type: Review

References (71)

1. Reith W Mach B The bare lymphocyte syndrome and the regulation of mhc expression Annu Rev Immunol 2001 19 331 73
2. Ting JP Trowsdale J Genetic control of MHC class II expression Cell 2002 109 S21 33
3. Boss JM Jensen PE Transcriptional regulation of the MHC class II antigen presentation pathway Curr Opin Immunol 2003 15 105 11
4. Cresswell P Assembly, transport, and function of MHC class II molecules Annu Rev Immunol 1994 12 259 93
5. Viret C Janeway CAJ MHC and T cell development Rev Immunogenet 1999 1 91 104
6. Al-Daccak R Mooney N Charron D MHC class II signaling in antigen-presenting cells Curr Opin Immunol 2004 16 108 13
7. Zika E Ting JP Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes Curr Opin Immunol 2005 17 58 64
8. Reith W Leibundgut-Landmann S Waldburger JM Regulation of MHC class II gene expression by the class II transactivator Nat Rev Immunol 2005 5 793 806
9. Landmann S Muhlethaler-Mottet A Bernasconi L et al. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class ii transactivator (ciita) expression J Exp Med 2001 194 379 92
10. Leibundgut-Landmann S Waldburger JM Reis e Sousa C Acha-Orbea H Reith W MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells Nat Immunol 2004 5 899 908
11. Holling TM van der Stoep N Quinten E van den Elsen PJ Activated human T cells accomplish MHC class ii expression through T cell-specific occupation of class II transactivator promoter III J Immunol 2002 168 763 70
12. Wong AW Ghosh N Mckinnon KP et al. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line J Immunol 2002 169 3112 9
13. Klein C Lisowska Grospierre B LeDeist F Fischer A Griscelli C Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome J Pediatr 1993 123 921 8
14. Elhasid R Etzioni A Major histocompatibility complex class II deficiency: a clinical review Blood Rev 1996 10 242 8
15. Guardiola J Maffei A Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases Crit Rev Immunol 1993 13 247 68
16. Prod'homme T Dekel B Barbieri G et al. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course Immunogenetics 2003 55 530 9
17. Nekrep N Jabrane-Ferrat N Wolf HM Eibl MM Geyer M Peterlin BM Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome Nat Immunol 2002 3 1075 81
18. Wiszniewski W Fondaneche MC Le Deist F et al. Mutation in the class II trans-activator leading to a mild immunodeficiency J Immunol 2001 167 1787 94
19. Rieux Laucat F Le Deist F Selz F Fischer A de Villartay JP Normal T cell receptor V beta usage in a primary immunodeficiency associated with HLA class II deficiency Eur J Immunol 1993 23 928 34
20. Steimle V Otten LA Zufferey M Mach B Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency Cell 1993 75 135 46
21. Masternak K Barras E Zufferey M et al. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients Nat Genet 1998 20 273 7
22. Nagarajan UM Louis-Plence P Desandro A Nilsen R Bushey A Boss JM RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency Immunity 1999 10 153 62
23. Steimle V Durand B Barras E et al. A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (Bare Lymphocyte Syndrome) Genes Dev 1995 9 1021 32
24. Durand B Sperisen P Emery P et al. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency EMBO J 1997 16 1045 55
25. Desandro AM Nagarajan UM Boss JM Associations and interactions between bare lymphocyte syndrome factors Mol Cell Biol 2000 20 6587 99
26. Nekrep N Geyer M Jabrane-Ferrat N Peterlin BM Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome Mol Cell Biol 2001 21 5566 76
27. Krawczyk M Masternak K Zufferey M Barras E Reith W New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study Mol Cell Biol 2005 25 8607 18
28. Gajiwala KS Chen H Cornille F et al. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding Nature 2000 403 916 21
29. Peretti M Villard J Barras E Zufferey M Reith W Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP Mol Cell Biol 2001 21 5699 709
30. Dziembowska M Fondaneche MC Vedrenne J et al. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency Immunogenetics 2002 53 821 9
31. Chang CH Guerder S Hong SC van Ewijk W Flavell RA Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression Immunity 1996 4 167 78
32. Clausen BE Waldburger JM Schwenk F et al. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice Immunity 1998 8 143 55
33. Itoh-Lindstrom Y Piskurich JF Felix NJ et al. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain J Immunol 1999 163 2425 31
34. Buch T Polic B Clausen BE et al. MHC class II expression through a hitherto unknown pathway supports T helper cell dependent immune responses: implications for MHC class II deficiency Blood 2005 Oct 27 [Epub ahead of print].
35. Masternak K Peyraud N Krawczyk M Barras E Reith W Chromatin remodeling and extragenic transcription at the MHC class II locus control region Nat Immunol 2003 4 132 7
36. Krawczyk M Peyraud N Rybtsova N et al. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA J Immunol 2004 173 6200 10
37. Gomez JA Majumder P Nagarajan UM Boss JM X box-like sequences in the MHC class II region maintain regulatory function J Immunol 2005 175 1030 40
38. Moore BB Cao ZA Mcrae TL Woo CH Conley S Jones PP The invariant chain gene intronic enhancer shows homology to class II promoter elements J Immunol 1998 161 1844 52
39. Muhlethaler-Mottet A Krawczyk M Masternak K et al. The S box of MHC class II promoters is a key determinant for recruitment of the transcriptional coactivator CIITA J Biol Chem 2004 279 40529 35
40. Zhu XS Linhoff MW Li G Chin KC Maity SN Ting JP Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter Mol Cell Biol 2000 20 6051 61
41. Masternak K Muhlethaler-Mottet A Villard J Zufferey M Steimle V Reith W CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex Genes Dev 2000 14 1156 66
42. Masternak K Reith W Promoter-specific functions of CIITA and the MHC class II enhancesosome in transcriptional activation EMBO J 2002 21 1379 88
43. Spilianakis C Kretsovali A Agalioti T Makatounakis T Thanos D Papamatheakis J CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II EMBO J 2003 22 5125 36
44. Mckinsey TA Kuwahara K Bezprozvannaya S Olson EN Class II histone deacetylases confer signal-responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK Mol Biol Cell 2006 17 438 47
45. Wang AH Gregoire S Zika E et al. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases J Biol Chem 2005 280 29117 27
46. Zika E Greer SF Zhu XS Ting JP Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation Mol Cell Biol 2003 23 3091 102
47. Leibundgut-Landmann S Waldburger JM Krawczyk M et al. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes Eur J Immunol 2004 34 1513 25
48. Xu Y Wang L Buttice G Sengupta PK Smith BD Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma) J Biol Chem 2004 279 41319 32
49. Mahanta SK Scholl T Yang FC Strominger JL Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein Proc Natl Acad Sci USA 1997 94 6324 9
50. Fontes JD Jiang B Peterlin BM The class II trans-activator CIITA interacts with the TBP-associated factor TAF II 32 Nucleic Acids Res 1997 25 2522 8
51. Kanazawa S Okamoto T Peterlin BM Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection Immunity 2000 12 61 70
52. Beresford GW Boss JM CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter Nat Immunol 2001 2 652 7
53. Kretsovali A Agalioti T Spilianakis C Tzortzakaki E Merika M Papamatheakis J Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator Mol Cell Biol 1998 18 6777 83
54. Fontes JD Kanazawa S Jean D Peterlin BM Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes Mol Cell Biol 1999 19 941 7
55. Tzortzakaki E Spilianakis C Zika E Kretsovali A Papamatheakis J Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways Mol Endocrinol 2003 17 2509 18
56. Raval A Howcroft TK Weissman JD et al. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250 Mol Cell 2001 7 105 15
57. Zika E Fauquier L Vandel L Ting JP Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression Proc Natl Acad Sci USA 2005 102 16321 6
58. Mudhasani R Fontes JD The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes Mol Cell Biol 2002 22 5019 26
59. Ting JP Davis BK Caterpiller: a novel gene family important in immunity, cell death, and diseases Annu Rev Immunol 2005 23 387 414
60. Inohara N Chamaillard M Mcdonald C Nunez G NOD-LRR proteins: role in host-microbial interactions and inflammatory disease Annu Rev Biochem 2005 74 355 83
61. Kufer TA Fritz JH Philpott DJ NACHT-LRR proteins (NLRs) in bacterial infection and immunity Trends Microbiol 2005 13 381 8
62. Inohara N Nunez G NODs: intracellular proteins involved in inflammation and apoptosis Nat Rev Immunol 2003 3 371 82
63. Hake SB Masternak K Kammerbauer C Janzen C Reith W Steimle V CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation Mol Cell Biol 2000 20 7716 25
64. Towey M Kelly AP Nuclear localisation of CIITA is controlled by a carboxy terminal leucine-rich repeat region Mol Immunol 2002 38 627 34
65. Harton JA Cressman DE Chin KC Der CJ Ting JP GTP binding by class II transactivator: role in nuclear import Science 1999 285 1402 5
66. Harton JA O'Connor W Conti BJ Linhoff MW Ting JP Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation Hum Immunol 2002 63 588 601
67. Kretsovali A Spilianakis C Dimakopoulos A Makatounakis T Papamatheakis J Self association of class II transactivator correlates with its intracellular localization and transactivation J Biol Chem 2001 276 32191 7
68. Linhoff MW Harton JA Cressman DE Martin BK Ting JP Two distinct domains within CIITA mediate self association: involvement of the GTP-binding and leucine-rich repeat domains Mol Cell Biol 2001 21 3001 11
69. Raval A Weissman JD Howcroft TK Singer DS The GTP-binding domain of class II transactivator regulates its nuclear export J Immunol 2003 170 922 30
70. Zhu XS Ting JP A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters Mol Cell Biol 2001 21 7078 88
71. Spilianakis C Papamatheakis J Kretsovali A Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes Mol Cell Biol 2000 20 8489 98